Pfizer Limited — Important, 05-02-2025: General Updates

Pfizer Limited has faced a significant tax-related challenge, receiving an order from the Central Goods and Service Tax Office in Mohali, Punjab. The order denies a transitional credit claim while levying a total tax demand of ₹1.77 crore (cr), which includes ₹54.07 lakh as the principal tax, ₹69.36 lakh in interest, and another ₹54.07 lakh as a penalty. The company contends that this demand is unjustifiable and is actively appealing against the order. Importantly, Pfizer believes that this issue will not materially affect its financials, operations, or strategic activities, underscoring a resilient position in managing regulatory challenges. Investors should monitor developments in this matter closely but can maintain confidence in the company's operational stability amidst the ongoing appeal process.